Sympathectomy or Doxazosin, But Not Propranolol, Blunt Myocardial Interstitial Fibrosis in Pressure-Overload Hypertrophy
- 1 November 2005
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 46 (5), 1213-1218
- https://doi.org/10.1161/01.hyp.0000185689.65045.4c
Abstract
The adaptive changes that develop in the pressure-overloaded left ventricular (LV) myocardium include cardiomyocyte hypertrophy and interstitial fibrosis. Although the former is known to depend to a sizeable extent on sympathetic (over)activity, little information exists whether the same applies to the latter, ie, whether excess catecholamine exposure contributes to the imbalance between collagen deposition by fibroblasts and degradation by matrix metalloproteases (MMPs), eventually leading to LV collagen accumulation. Sprague-Dawley rats were subjected to abdominal aortic banding (B) or sham operation (S) and treated with β-blockade (Bb, oral propranolol, 40 mg/kg per day), chemical sympathectomy (Sx, 6-hydroxydopamine, 150 mg/kg intraperitoneal twice per week) or vehicle (Vh). Ten weeks later, systolic blood pressure, LV weight, collagen abundance (computer-aided histology), zymographic matrix metalloproteinase (MMP)-2 activity and its specific tissue inhibitor concentration (TIMP-2) were measured. Both sympathectomy and β-blockade failed to attenuate the banding-induced blood pressure elevation but significantly attenuated the attendant LV hypertrophy. As expected, pressure-overload hypertrophy was associated with interstitial fibrosis (collagen: 4.37±1.23% BVh versus 1.23±0.44% SVh, P P =not significant versus SSx) but left unchanged by β-blockade (4.11±1.23%, P P <0.05), indicating reduced interstitial collagenolytic activity. In separate groups of banded and sham-operated rats, treatment with the α-receptor blocker doxazosin (10 mg/kg per day) displayed similar antifibrotic and biochemical effects as sympathectomy. Thus in the course of experimental pressure overload, the sympathetic nervous system plays a major pro-fibrotic role, which is mediated via α-adrenergic but not β-adrenergic receptors.Keywords
This publication has 22 references indexed in Scilit:
- Increased endothelin-1 production in patients with chronic heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Regression of Isoproterenol-Induced Cardiac Hypertrophy by Na + /H + Exchanger InhibitionHypertension, 2003
- Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunitiesActa Physiologica Scandinavica, 2003
- Adrenergic pathways and left ventricular remodelingJournal of Cardiac Failure, 2002
- Attenuation of aortic banding-induced cardiac hypertrophy by propranolol is independent of β-adrenoceptor blockadeJournal Of Hypertension, 2002
- β-Adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic Gsα mouseJCI Insight, 1999
- Remodelling of Cardiac Extracellular Matrix duringβ-adrenergic Stimulation: Upregulation of SPARC in the Myocardium of Adult Rats,Journal of Molecular and Cellular Cardiology, 1998
- Potentiation of the baroreceptor-heart rate reflex by sympathectomy in conscious rats.Hypertension, 1991
- Effects of Doxazosin on Vascular Collagen Synthesis, Arterial Pressure and Serum Lipids in the Spontaneously Hypertensive RatJournal of Cardiovascular Pharmacology, 1987
- Modified Elastic Tissue-Masson Trichrome StainStain Technology, 1984